Wen X, Zhang B, Wu B, Haitao X, Zehua L, Ruoyu L, et al. Signalling pathways in obesity: mechanisms and therapeutic interventions. Sign Transduct Target Ther. 2022;7:298.

Article  Google Scholar 

Phelps NH, Singleton RK, Zhou B, Heap RA, Mishra A, Bennett JE, et al. Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet. 2024;403:1027–50.

Article  Google Scholar 

Savova MS, Mihaylova LV, Tews D, Wabitsch M, Georgiev MI. Targeting PI3K/AKT signaling pathway in obesity. Biomed Pharmacother. 2023;159:114244.

Article  CAS  PubMed  Google Scholar 

Muller TD, Blüher M, Tschöp MH, DiMarchi RD. Anti-obesity drug discovery: advances and challenges. Nat Rev Drug Discov. 2022;21:201–23.

Article  PubMed  Google Scholar 

Zhao XY, Wang JQ, Neely GG, Shi YC, Wang QP. Natural compounds as obesity pharmacotherapies. Phytother Res. 2024;38:797–838.

Article  CAS  PubMed  Google Scholar 

Holmback U, Grudén S, Litorp H, Willhems D, Kuusk S, Alderborn G, et al. Effects of a novel weight-loss combination product containing orlistat and acarbose on obesity: A randomized, placebo-controlled trial. Obesity. 2022;30:2222–32.

Article  CAS  PubMed  Google Scholar 

Longo VD, Di Tano M, Mattson MP, Guidi N. Intermittent and periodic fasting, longevity and disease. Nat Aging. 2021;1:47–59.

Article  PubMed  PubMed Central  Google Scholar 

Weir HJ, Yao P, Huynh FK, Escoubas CC, Goncalves RL, Burkewitz K, et al. Dietary restriction and AMPK increase lifespan via mitochondrial network and peroxisome remodelling. Cell Metab. 2017;26:884–96.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Madeo F, Carmona-Gutierrez D, Hofer SJ, Kroemer G. Caloric restriction mimetics against age-associated disease: targets, mechanisms, and therapeutic potential. Cell Metab. 2019;29:592–610.

Article  CAS  PubMed  Google Scholar 

Wei M, Brandhorlistat S, Shelehchi M, Mirzaei H, Cheng CW, Budniak J, et al. Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease. Sci Transl Med. 2017;15:eaai8700.

Article  Google Scholar 

Atanasov AG, Zotchev SB, Dirsch VM, Orhan IE, Banach M, Rollinger JM, et al. Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov. 2021;20:200–16.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thomas C, Erni R, Wu JY, Fischer F, Lamers G, Grigolon G, et al. A naturally occurring polyacetylene isolated from carrots promotes health and delays signatures of aging. Nat Commun. 2023;14:8142.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bolger GT, Pucaj K, Minta YO, Sordillo P. Relationship between the in vitro efficacy, pharmacokinetics and in vivo efficacy of curcumin. Biochem Pharmacol. 2022;205:115251. https://doi.org/10.1016/j.bcp.2022.115251.

Article  CAS  PubMed  Google Scholar 

Vasileva LV, Saracheva KE, Ivanovska MV, Petrova AP, Marchev AS, Georgiev MI, et al. Antidepressant-like effect of salidroside and curcumin on the immunoreactivity of rats subjected to a chronic mild stress model. Food Chem Toxicol. 2018;121:604–11.

Article  CAS  PubMed  Google Scholar 

Shin JW, Chun KS, Kim DH, Kim SJ, Kim SH, Cho NC, et al. Curcumin induces stabilization of Nrf2 protein through Keap1 cysteine modification. Biochem Pharmacol. 2020;173:113820.

Article  CAS  PubMed  Google Scholar 

Ren L, Zhan P, Wang Q, Wang C, Liu Y, Yu Z, et al. Curcumin upregulates the Nrf2 system by repressing inflammatory signalling-mediated Keap1 expression in insulin-resistant conditions. Biochem Biophys Res Commun. 2019;514:691–8.

Article  CAS  PubMed  Google Scholar 

Li N, Yan X, Huang W, Chu M, Dong Y, Song H, et al. Curcumin protects against the age-related hearing loss by attenuating apoptosis and senescence via activating Nrf2 signaling in cochlear hair cells. Biochem Pharmacol. 2023;212:115575.

Article  CAS  PubMed  Google Scholar 

Wu X, Zhou X, Lai S, Liu J, Qi J. Curcumin activates Nrf2/HO-1 signaling to relieve diabetic cardiomyopathy injury by reducing ROS in vitro and in vivo. FASEB J. 2022;36:e22505.

Article  CAS  PubMed  Google Scholar 

Sampath C, Wilus D, Tabatabai M, Freeman ML, Gangula PR. Mechanistic role of antioxidants in rescuing delayed gastric emptying in high fat diet induced diabetic female mice. Biomed Pharmacoth. 2021;137:111370.

Article  CAS  Google Scholar 

Vasileva LV, Savova MS, Amirova KM, Dinkova-Kostova AT, Georgiev MI. Obesity and NRF2-mediated cytoprotection: Where is the missing link? Pharmacol Res. 2020;156:104760.

Article  CAS  PubMed  Google Scholar 

Paek J, Jacqueline YL, Naracimhan SD, Nguyen TN, Glover-Cutter K, Robida-Stubbs S, et al. Mitochondrial SKN-1/Nrf mediates a conserved starvation response. Cell Metab. 2012;16:526–3.

Frankino PA, Siddiqi TF, Bolas T, Bar-Ziv R, Gildea HK, Zhang H, et al. SKN-1 regulates stress resistance downstream of amino catabolism pathways. iScience. 2022;25:104571.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pang S, Lynn D, Lo J, Paek J, Curran SP. SKN-1 and Nrf2 couples proline catabolism with lipid metabolism during nutrient deprivation. Nat Commun. 2014;5:5048.

Article  CAS  PubMed  Google Scholar 

Blackwell TK, Steinbaugh MJ, Hourihan JM, Ewald CY, Isik M. SKN-1/Nrf, stress responses, and aging in Caenorhabditis elegans. Free Radic Biol Med. 2015;88:290–301.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Costa RM, Dias MC, Alves JV, Silva JLM, Rodrigues D, Silva JF, et al. Pharmacological activation of nuclear factor erythroid 2-related factor-2 prevents hyperglycemia-induced renal oxidative damage: Possible involvement of O-GlcNAcylation. Biochem Pharmacol. 2024;220:115982.

Article  CAS  PubMed  Google Scholar 

Steinbaugh MJ, Narasimhan SD, Robida-Stubbs S, Moronetti Mazzeo LE, Dreyfuss JM, Hourihan JM, et al. Lipid-mediated regulation of SKN-1/Nrf in response to germ cell absence. eLife. 2015;4:e07836.

Article  PubMed  PubMed Central  Google Scholar 

Dou Y, Huang R, Li Q, Liu Y, Li Y, Chen H, et al. Oxyberberine, an absorbed metabolite of berberine, possess superior hypoglycemic effect via regulating the PI3K/Akt and Nrf2 signalling pathways. Biomed Pharmacother. 2021;137:111312.

Article  CAS  PubMed  Google Scholar 

Gao W, Wang W, Zhang J, Deng P, Hu J, Yang J, et al. Allicin ameliorates obesity comorbid depressive-like behaviors: involvement of the oxidative stress, mitochondrial function, autophagy, insulin resistance and NOX/Nrf2 imbalance in mice. Metab Brain Dis. 2019;34:1267–80.

Article  CAS  PubMed  Google Scholar 

Islam MT, Tuday E, Allen S, Kim J, Trott DW, Holland WL, et al. Senolytic drugs, dasatinib and quercetin, attenuate adipose tissue inflammation, and ameliorate metabolic function in old age. Aging Cell. 2023;22:e13767.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Novais EJ, Tran VA, Johnston SN, Darris KR, Roupas AJ, Sessions GA, et al. Long-term treatment with senolytic drugs dasatinib and quercetin ameliorates age-dependent intervertebral disc degeneration in mice. Nat Commun. 2021;12:5213.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang SL, Chang TC, Sun NK. Curcumin reduces paclitaxel resistance in ovarian carcinoma cells by upregulating SNIP1 and inhibiting NFκB activity. Biochem Pharmacol. 2023;212:115581.

Article  CAS  PubMed  Google Scholar